High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A*02:01 molecules.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
19 07 2019
Historique:
received: 13 08 2018
accepted: 21 06 2019
entrez: 21 7 2019
pubmed: 22 7 2019
medline: 2 6 2020
Statut: ppublish

Résumé

Major histocompatibility complex (MHC) class I molecules present short peptide ligands on the cell surface for interrogation by cytotoxic CD8

Identifiants

pubmed: 31324691
pii: 4/37/eaav0860
doi: 10.1126/sciimmunol.aav0860
pii:
doi:

Substances chimiques

HLA-A*02:01 antigen 0
HLA-A2 Antigen 0
Peptides 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Andreas Moritz (A)

Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany. andreas.moritz@student.uni-tuebingen.de maurer@immatics.com.
Immatics Biotechnologies GmbH, Tübingen, Germany.

Raghavendra Anjanappa (R)

Department of Life Sciences and Chemistry, Jacobs University, Bremen, Germany.

Claudia Wagner (C)

Immatics Biotechnologies GmbH, Tübingen, Germany.

Sebastian Bunk (S)

Immatics Biotechnologies GmbH, Tübingen, Germany.

Martin Hofmann (M)

Immatics Biotechnologies GmbH, Tübingen, Germany.

Gabriele Pszolla (G)

Immatics Biotechnologies GmbH, Tübingen, Germany.

Ankur Saikia (A)

Department of Life Sciences and Chemistry, Jacobs University, Bremen, Germany.

Maria Garcia-Alai (M)

European Molecular Biology Laboratory (EMBL), Hamburg Outstation, Notkestrasse 85, D-22607 Hamburg, Germany.

Rob Meijers (R)

European Molecular Biology Laboratory (EMBL), Hamburg Outstation, Notkestrasse 85, D-22607 Hamburg, Germany.

Hans-Georg Rammensee (HG)

Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany.

Sebastian Springer (S)

Department of Life Sciences and Chemistry, Jacobs University, Bremen, Germany.

Dominik Maurer (D)

Immatics Biotechnologies GmbH, Tübingen, Germany. andreas.moritz@student.uni-tuebingen.de maurer@immatics.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH